programme for high-risk individuals along with instigating new population strategies such as differentially taxing sugary drinks. However, to have a meaningful impact, such programmes will need to be implemented in the low and middle-income countries where the majority of the burden exists. Along with individual-level interventions, data are also emerging on the effectiveness of using targeted taxes to modify purchasing behaviour of unhealthy food stuffs. For example, in 2013 the Mexican government passed legislation requiring a fixed tax on sugar-sweetened beverages and a sales tax on several highly energy dense foods 7 . By 2014 this initiative had led to the average urban-dwelling individual in Mexico purchasing 4,241 ml (that is, seven 600 ml bottles) fewer taxed beverages than expected based on pretax trends 7 . Technology also has an important role in disease prevention. For example with increasing access to mobile phones in developing countries, the potential for their use in prevention and disease management is huge. For example, in India the most affordable mobile phone, priced at <US$4, has been launched and mobile phone messaging has been shown to be an effective and acceptable method of delivering lifestyle interventions 8 . In addition to simple prevention, the burden of T2DM can be reduced by using optimal medical management pathways for those that have the disease. Achieving tight glycaemic control early in the disease trajectory has beneficial effects on macrovascular and microvascular complications and mortality 9 . Despite this evidence, globally, people who have T2DM are not adequately reaching these targets. Once diagnosed, patients need access to antidiabetic, hypertensive and lipid-lowering medications to prevent long-term complications of T2DM or as in the case of type 1 diabetes mellitus, ensure their survival. Unfortunately, access to medications for managing non-communicable diseases is very low globally. Only a small proportion (<10%) of the WHO's list of essential medications including statins, antihypertensive and antidiabetic medications are available in many low-income and middle-income countries 10 .
In conclusion, the study from NCD-RisC quantifies a known trend of rising levels of diabetes mellitus globally. Theoretically, as the causes for the most common form, T2DM, are well established and related to known modifiable lifestyle and environmental factors, we as a society have the opportunity to act. Co-ordinated global efforts to change policies within each country are now required to improve diet quality and increase physical activity if we are to halt this 'tsunami' of diabetes mellitus. Governments in low and middle-income countries in particular need to implement policies to ensure that essential antidiabetic and cardiovascular medications are available in all countries. Access to these medications should not be a privilege but a basic human right and viewed with the same urgency as one would with a new pandemic of infectious disease.
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Healthy ageing, the genome and the environment
Kaare Christensen & Matt McGue
The sequenced genomes of individuals aged ≥80 years, who were highly educated, self-referred volunteers and with no self-reported chronic diseases were compared to young controls. In these data, healthy ageing is a distinct phenotype from exceptional longevity and genetic factors that protect against disease might be enriched in this population. Exceptional longevity is an easily measured phenotype in countries that have reliable population-based data registries. These data have enabled the pooling of genome-wide association studies (GWAS), but even when the combined sample size is large, very few common genetic variants associated with longevity have been identified, and all have modest effect sizes 1 . Erikson and colleagues could not identify associations with most known longevity variants, which might reflect the distinct nature of longevity and healthy ageing. Alternatively, the result could be a consequence of the sample size, which although large for a WGS ageing study, would be considered quite small for the purpose of detecting genetic variants. Interestingly, although no single locus was found to be of genome-wide significance when comparing wellderly individuals to controls, variants associated with cognitive function were significantly over-represented among their top GWAS hits such as a linkage block at MHC locus 6p22.1. The maintenance of cognitive function might be a key contributor to healthy ageing. Nevertheless, the method by which the sample was identified might also have contributed to the results on cognition. The individuals defined as wellderly in this study were recruited through various media solicitations (such as radio, newsletter, newspaper advertisements). A non-random sub-sample of the population is known to respond to such solicitations 6 and that seems to be the case here. Among the wellderly in the study by Erikson et al., 82% had a college degree versus just 19% in the background population 2 . On this background, that the wellderly were enriched with genetic factors associated with cognitive function might not be surprising, especially given that in the control group of 20-44 year olds, one-third were parents of a preterm neonate, a group of individuals who are known to be associated with an adverse socioeconomic position 7 . As the wellderly population increases in size and the statistical power to detect genetic variants increases, confirming that the cognitive function results are meaningful in healthy ageing, rather than simply the peculiarities of sampling, will be important.
Wellderly individuals might be distinguished as much by the lifestyles they lead as the genes they inherit. For example, in a 2015 population-based study that included the offspring of long-lived siblings (surviving to at least 90 years of age) the offspring had one third of the expected lung cancer incidence 8 .
As the incidence of lung cancer is strongly correlated with lifestyle, these findings suggest that a healthy lifestyle might be a main driver for the familial clustering of exceptional good health. A similar phenomenon might be operating in the wellderly sample, which was distinguished by a high prevalence of exercise (67% versus 44% in controls) but, surprisingly, also by slightly increased rates of having ever smoked tobacco in men (61% versus 54% in controls) and no difference among women (42% versus 43%). However, high educational attainment is also associated with quitting smoking, so a high proportion of the highly educated wellderly might be ex-smokers. It therefore seems likely that the very highly educated wellderly individuals are healthier than their age peers in terms of current or lifetime exposure to tobacco smoking, but these data are unfortunately not reported in the Erikson et al. study. Nevertheless, as this study progresses, these data will provide a valuable opportunity to explore how lifestyle factors combine and interact with genetic factors to establish a healthy ageing phenotype.
With the lengthening of the human lifespan, comes a need to understand not only how we can live long, but also how we can live well. The comprehensive WGS study by Erikson and colleagues provides an important first step to create a shared data resource for identifying the common and rare genetic variants associated with healthy ageing. Progress will be most rapid when findings from WGS studies are combined with those from other genetic approaches, such as ongoing studies in longevity-enriched families, which have already been successful in identifying rare or novel genetic variants of importance to healthy ageing 9 . Ultimately, an understanding of both genetic and lifestyle factors will be needed to unravel the underlying mechanisms of long and healthy lives.
In the study, the authors define a 'wellderly' individual as being ≥80 years old who did not have any of a series of chronic diseases or was receiving medications. Being free of disease and older than 80 years of age seems to be a safe definition of healthy ageing. Nevertheless, whether an octogenarian individual is judged to be free of disease could hinge very much on diagnostic intensity, and the wellderly designation in this study was self-reported. In a population-based study of >700 individuals aged 85 years from Newcastle, UK 3 no participant after clinical examination was found to be free of all 18 diseases considered (including cancer, ischaemic heart disease, hypertension, diabetes mellitus, dementia, osteoporosis and arthritis) even though 40% of individuals rated their health as 'excellent' or 'very good' compared with others in their age group. Furthermore, the investigators found that many diseases might be severely underdiagnosed in this population. For example, atrial fibrillation was evident on electrocardiography in 14% of participants, of whom 28% had no such diagnosis in their general practice records. Arguments exist, therefore, for expanding the definition of healthy ageing beyond simple disease status. Physical and cognitive functioning are much more strongly associated with survival in the oldest individuals than presence or absence of disease 4 , and these functions make essential contributions to quality of life.
To show that healthy ageing was not merely the result of pure luck, Erikson et al. had the wellderly report on their siblings' mortality. Compared with the 1920s birth cohorts in the USA, the siblings of the wellderly had lower mortality. For instance, 83% of the wellderly siblings survived from age 10 to 70 years compared with 75% in the 1920s cohorts, indicating familial aggregation. Genetic variants influencing longevity might be reasonable candidates for healthy ageing. However, the investigators did not find any associations between the healthy ageing phenotype and the few longevity-associated gene variants that are currently known, such as FOXO3A -except for the most strongly-associated longevity variant, APOE. This result led the team to conclude that healthy ageing is an overlapping, but distinct phenotype, from exceptional longevity.
Arguments exist for expanding the definition of healthy ageing beyond simple diseases status
The maintenance of cognitive function might be a key contributor to healthy ageing
